APADAMTASE ALFA

APADAMTASE ALFA was reported 79 times

These side effects are most commonly reported by patients taking APADAMTASE ALFA:

# Side effect Count
0 PREGNANCY 13
1 NO ADVERSE EVENT 10
2 HAEMOLYSIS 6
3 THROMBOCYTOPENIA 6
4 DRUG INEFFECTIVE 5
5 HEADACHE 5
6 INCORRECT DOSE ADMINISTERED 5
7 NAUSEA 5
8 PRODUCT DOSE OMISSION ISSUE 5
9 THROMBOTIC THROMBOCYTOPENIC PURPURA 5
10 ABDOMINAL DISTENSION 4
11 ADAMTS13 ACTIVITY DECREASED 4
12 BLOOD BILIRUBIN INCREASED 4
13 BLOOD LACTATE DEHYDROGENASE INCREASED 4
14 BLOOD PRESSURE ABNORMAL 4
15 BLOOD URINE PRESENT 4
16 CARDIAC ARREST 4
17 FEELING COLD 4
18 HAEMORRHAGE 4
19 JAUNDICE 4
20 LOSS OF CONSCIOUSNESS 4
21 METABOLIC ACIDOSIS 4
22 MIOSIS 4
23 MYDRIASIS 4
24 OXYGEN SATURATION ABNORMAL 4
25 PALLOR 4
26 PLATELET COUNT INCREASED 4
27 PULMONARY OEDEMA 4
28 TONIC CONVULSION 4
29 UNRESPONSIVE TO STIMULI 4
30 VOMITING 4
31 BODY TEMPERATURE ABNORMAL 3
32 CEREBRAL INFARCTION 3
33 DEVICE MALFUNCTION 3
34 INHIBITING ANTIBODIES POSITIVE 3
35 MALAISE 3
36 PRODUCT RECONSTITUTION QUALITY ISSUE 3
37 ABDOMINAL PAIN 2
38 ABORTION SPONTANEOUS 2
39 CEREBROVASCULAR ACCIDENT 2
40 EXPOSURE DURING PREGNANCY 2
41 EXTRA DOSE ADMINISTERED 2
42 HYPERTENSION 2
43 LOW BIRTH WEIGHT BABY 2
44 MIGRAINE 2
45 NASOPHARYNGITIS 2
46 OFF LABEL USE 2
47 POOR VENOUS ACCESS 2
48 PRODUCT DISTRIBUTION ISSUE 2
49 PRODUCT USE ISSUE 2
50 TRANSIENT ISCHAEMIC ATTACK 2
51 UNDERDOSE 2
52 ABDOMINAL PAIN UPPER 1
53 ADAMTS13 ACTIVITY INCREASED 1
54 ARTHRALGIA 1
55 ASTHENIA 1
56 ASTHMA 1
57 BLOOD POTASSIUM ABNORMAL 1
58 BLOOD PRESSURE INCREASED 1
59 BLOOD TEST ABNORMAL 1
60 BODY TEMPERATURE DECREASED 1
61 BRAIN FOG 1
62 BREAST FEEDING 1
63 BREAST PAIN 1
64 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
65 CLOSTRIDIUM DIFFICILE COLITIS 1
66 CONFUSIONAL STATE 1
67 CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA 1
68 CORONAVIRUS INFECTION 1
69 COUGH 1
70 DEATH 1
71 DEPRESSION 1
72 DEVICE LEAKAGE 1
73 DISEASE RECURRENCE 1
74 DIZZINESS 1
75 DRUG HYPERSENSITIVITY 1
76 DRUG LEVEL ABNORMAL 1
77 DRUG LEVEL DECREASED 1
78 DYSARTHRIA 1
79 DYSCHROMATOPSIA 1
80 EXPOSURE VIA BREAST MILK 1
81 EYE IRRITATION 1
82 FALL 1
83 FEELING HOT 1
84 FLUSHING 1
85 FUNGAL INFECTION 1
86 GASTROINTESTINAL INFECTION 1
87 GENERAL PHYSICAL HEALTH DETERIORATION 1
88 GIANT CELL TUMOUR OF TENDON SHEATH 1
89 HAEMATURIA 1
90 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
91 INCREASED TENDENCY TO BRUISE 1
92 INSURANCE ISSUE 1
93 IRON DEFICIENCY 1
94 ISCHAEMIC STROKE 1
95 LACRIMATION INCREASED 1
96 LARYNGOSPASM 1
97 LIQUID PRODUCT PHYSICAL ISSUE 1
98 LUNG ADENOCARCINOMA 1
99 MATERNAL EXPOSURE DURING DELIVERY 1
100 MENISCUS INJURY 1
101 METASTASES TO PERITONEUM 1
102 MIGRAINE WITH AURA 1
103 NEOPLASM MALIGNANT 1
104 NERVOUS SYSTEM DISORDER 1
105 NEUROLOGICAL SYMPTOM 1
106 NEUTROPHIL COUNT DECREASED 1
107 OVARIAN CANCER 1
108 OVARIAN CYST 1
109 PAIN 1
110 PAIN IN EXTREMITY 1
111 PANCREATITIS NECROTISING 1
112 PARANASAL SINUS DISCOMFORT 1
113 PHOTOPHOBIA 1
114 PLACENTAL INSUFFICIENCY 1
115 PRE-ECLAMPSIA 1
116 PREMATURE BABY 1
117 PRESCRIBED OVERDOSE 1
118 PRODUCT AVAILABILITY ISSUE 1
119 PRODUCT DISPENSING ERROR 1
120 PROTEINURIA 1
121 PRURITUS 1
122 PYREXIA 1
123 SOMNOLENCE 1
124 TACHYCARDIA 1
125 THERAPEUTIC RESPONSE DECREASED 1
126 THERAPY NON-RESPONDER 1
127 THROMBOTIC MICROANGIOPATHY 1
128 UMBILICAL CORD THROMBOSIS 1
129 VAGINAL HAEMORRHAGE 1
130 VAGINAL INFECTION 1
131 VEIN RUPTURE 1
132 VENTRICULAR SEPTAL DEFECT 1
133 VIRAL INFECTION 1
134 VISUAL IMPAIRMENT 1
135 VULVOVAGINAL INJURY 1
136 VULVOVAGINAL MYCOTIC INFECTION 1
137 WEIGHT FLUCTUATION 1
138 WEIGHT INCREASED 1
139 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1